Antibody-Cell Conjugation Technology: Cutting-Edge Platform for Off-the-Shelf Cell Therapies
Time: 10:15 am
day: Conference Day One
Details:
- Advantages of ACC technology in developing allogeneic cell therapies
- Mechanism of action of antibody-conjugated gamma delta T cells against tumors
- Preclinical evidence of ACC products against hematologic and solid malignancies
- Updates for IND application of ACC products
